Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05740865
Other study ID # Neurospine_infection
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2012
Est. completion date January 20, 2023

Study information

Verified date April 2023
Source Xuanwu Hospital, Beijing
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Surgical site infection (SSI), particularly deep SSI, is one of the most serious complications after spinal surgery. evaluating the risk of SSI and, correspondingly, prescription of prophylactic measures are extremely important to prevent SSI and avoid potentially devastating consequences. A retrospective study was conducted aiming to develop a point-based prediction model of deep surgical site infection in patients receiving open posterior instrumented thoracolumbar surgery.


Description:

Data of 3,419 patients in 4 hospitals from Jan 1, 2012 to Dec 30, 2021 were retrospectively collected and were evaluated aiming to develop a point-based prediction model of deep surgical site infection in patients receiving open posterior instrumented thoracolumbar surgery. Clinical knowledge-driven, data-driven and decision tree model was used to identify predictive variables of deep SSI. Internal validation was performed by using bootstrapping methods.


Recruitment information / eligibility

Status Completed
Enrollment 3419
Est. completion date January 20, 2023
Est. primary completion date December 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: patients who previously received open posterior instrumented thoracolumbar surgery Exclusion Criteria: 1. were aged < 18 years; 2. underwent surgery for the spinal infection, spine revision surgery, or cervical operation; 3. were diagnosed as superficial SSI; 4. died in hospital; 5. diagnosis of SSI was not determined; 6. had missing data more than 10% were excluded.

Study Design


Intervention

Procedure:
open posterior instrumented thoracolumbar surgery
Both group previously received open posterior instrumented thoracolumbar surgery in 4 centers

Locations

Country Name City State
China Xuanwu Hospital, China International Neuroscience Institute, Capital Medical University Beijing

Sponsors (1)

Lead Sponsor Collaborator
Xuanwu Hospital, Beijing

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary deep surgical site infection deep SSI was defined as an infection occurring within 30 days after the operation involving deep soft tissues along with one of the following criterion: (1)purulent drainage from the deep incision but not from the organ/space component of the surgical site;(2) a deep incision spontaneously dehisces or is deliberately opened by a surgeon when the patient has at least one of the following signs or symptoms: fever >38?, localized pain, or tenderness, unless site is culture-negative;(3) an abscess or other evidence of infection involving the deep incision is found on direct examination, during reoperation, or by histopathologic or radiologic examination;(4) diagnosis of a deep incisional SSI by a surgeon or attending physician. In this study, organ space SSI was also classified as deep SSI due to the same criteria as deep SSI. within 30 days after the operation
See also
  Status Clinical Trial Phase
Completed NCT00967109 - Establishment of Optimal Transfusion Threshold During Spine Surgery N/A
Terminated NCT00805844 - Motor Evoked Potentials and SedLine N/A
Terminated NCT05494125 - Effects of Continuous ESP Catheters on Recovery, Pain and Opioid Consumption After Multilevel Spine Surgery N/A
Recruiting NCT06210061 - Propofol-Fentanyl-Dexmedetomidine and Propofol-Fentanyl-Sevoflurane Anesthesia for Major Spine Surgery Under Somato Sensory- and Motor- Evoked Potential Monitoring N/A
Completed NCT05016739 - Use of CADISS Medical Device to Facilitate Dissection of Epidural Fibrosis in Revision Spine Surgery N/A
Not yet recruiting NCT05478382 - Pregabalin is an Effective Treatment for Acute Postoperative Pain Following Spinal Surgery Without Major Side Effects Phase 4
Not yet recruiting NCT05015036 - Evaluation of an Enhanced Recovery Protocol After Minimally Invasive Lumbar Surgery.
Not yet recruiting NCT02551302 - "Efficacy of Hybrid Systems ("Topping Off") Versus Rigid Spinal Fusion in Lumbar Fusion Surgery: A Dual-center, Prospective, Randomized Pilot Study ("CD Horizon BalanC")" N/A
Not yet recruiting NCT05693675 - Postoperative Oral Methadone After Major Spine Surgery; Safety, Feasibility and Efficacy in Prevention of Progression to Chronic Opioid Usage at 3 Months Phase 2/Phase 3
Completed NCT02884440 - Transverse Abdominis Plane Block for Anterior Approach Spine Surgery Phase 2
Completed NCT04574388 - Evaluation of Open-Label Conditioned Placebo Analgesia for Postoperative Opioid Reduction Following Spinal Fusion N/A
Completed NCT02949518 - Enhanced Recovery After Spine Surgery N/A
Completed NCT04473508 - Erectus Nerve Block for Lumbar Spine Surgery Phase 3
Recruiting NCT05131854 - Incidence , Risk Factors and Outcomes of Haemodynamic Instability and Cardiac Arrest During Spine Surgery
Completed NCT03112993 - Speed of Recovery of Reversal of Neuromuscular Blockade in Geriatric Patients Undergoing Spine Surgery Phase 4
Completed NCT00840996 - Perioperative Intravenous Lidocaine or Epidural Anesthesia on Outcomes in Complex Spine Surgery N/A
Terminated NCT00696501 - Direct Stimulation Of Spinal Nerve Roots To Determine Sensory And Motor Innervation Patterns N/A
Recruiting NCT05626868 - Changes of Intra Abdominal Pressure During Surgeries in Prone Position as a Marker of Renal Damage
Recruiting NCT04797156 - Combined IV and Topical TXA in Major Spine Surgery Early Phase 1
Completed NCT02606695 - Comprehensive Spinal Alignment Planning Study